Synthesis of new compounds combining adamantanamine and monoterpene fragments and their antiviral activity against influenza virus A(H1N1)pdm09

Letters in Drug Design and Discovery

Volumn 10, Issue 6, 2013, Pages 477-485

  Teplov, George V ^a   Suslov, Evgeny V ^a   Zarubaev, Vladimir V ^b   Shtro, Anna A ^b   Karpinskaya, Liubov A ^b   Rogachev, Artem D ^a   Korchagina, Dina V ^a   Volcho, Konstantin P ^a   Salakhutdinov, Nariman F ^a   Kiselev, Oleg I ^b  

^a N N VOROZHTSOV NOVOSIBIRSK INSTITUTE OF ORGANIC CHEMISTRY   (Russian Federation)

^b Influenza Research Institute   (Russian Federation)

Author keywords

(H1N1)pdm09; Adamantyamine; Antiviral; Influenza; Monoterpenoid; Resistance

Indexed keywords

1 ADAMANTAN 1 YLAMINO 2 (2,2 DIMETHYLCYCLOPENT 3 EN 1 YL)PROPAN 2 OL; 1 ADAMANTYLAMINE; AMANTADINE DERIVATIVE; ANTIVIRUS AGENT; N (3,7 DIMETHYLOCTA 2,6 DIEN 1 YL)ADAMANTAN 1 AMINE; N (3,7 DIMETHYLOCTAL 6 EN 1 YL)ADAMANTAN 1 AMINE; N[[6,6 DIMETHYLBICYCLO(3 1 1)HEPT 2 EN 2 YL]METHYL]ADAMANTAN 1 AMINE; RIBAVIRIN; RIMANTADINE; TERPENE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ANTIVIRAL RESISTANCE; ARTICLE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG SELECTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; INFLUENZA VIRUS A H1N1; NONHUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE;

EID: 84879756004     PISSN: 15701808     EISSN: 1875628X     Source Type: Journal    
DOI: 10.2174/1570180811310060002     Document Type: Article

References (20)

1. Fiore, A.E.; Fry, A.; Shay, D.; Gubareva, L.; Bresee, J.S.; Uyeki, T.M. Antiviral agents for the treatment and chemoprophylaxis of influenza. MMWR Recommendations and Reports, 2011, 60(1), 1-26.
2. Ison, M. G. Antivirals and resistance: influenza virus. Curr. Opin. Virol., 2011, 1(6), 563-573.
3. Scholtissek, C.; Quack, G.; Klenk, H. D.; Webster, R. G. How to overcome resistance of influenza A viruses against adamantane derivatives. Antiviral Res., 1998, 37(2), 83-95.
4. Thorlund, K.; Awad, T.; Boivin, G.; Thabane, L. Systematic review of influenza resistance to the neuraminidase inhibitors. BMC Infect. Dis., 2011, 11, 134.
5. Hauge, S. H.; Dudman, S.; Borgen, K.; Lackenby, A.; Hungnes, O. Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007- 08. Emerg. Infect. Dis., 2009, 15(2), 155-162.
6. Davies, W. L.; Grunnert, R. R.; Haff, R. F.; McGahen, J. W.; Neumeyer, E. M.; Paulshock, M.; Watts, J. C.; Wood, T. R.; Hermann, E. C.; Hoffmann, C. E. Antiviral activity of 1-adamantamine (amantadine). Science, 1964, 144(3620), 862-863.
7. Wendel, H. A.; Snyder, M. T.; Pell, S. Trial of amantadine in epidemic influenza. Clin. Pharmacol. Ther., 1966, 7(1), 38-43.
8. Rabinovich, S.; Baldini, J. T.; Bannister, R. Treatment of influenza. The therapeutic efficacy of rimantadine HCl in a naturally occurring influenza A2 outbreak. Am. J. Med. Sci., 1969, 257, 328-335.
9. Shibnev, V. I.; Garaev, T. M.; Finogenova, M. P.; Shevchenko, E. S.; Burtseva, E. I. Some pathways to overcoming drug resistance of influenza A virus to adamantine derivatives. Pharm. Chem. Journ., 2012, 46(1), 1-5.
10. Schnell, J. R.; Chou, J. J. Structure and mechanism of the M2 proton channel of influenza A virus. Nature, 2008, 451(7178), 591-596.
11. Astani, A.; Reichling, J.; Schnitzler, P. Comparative study on the antiviral activity of selected monoterpenes derived from essential oils. Phytother. Res., 2010, 24(5), 673-679.
12. Ardashov, O. V.; Zarubaev, V. V.; Shtro, A. A.; Korchagina, D. V.; Volcho, K. P.; Salakhutdinov, N. F.; Kiselev, O. I. Antiviral activity of 3-methyl-6-(prop-1-en-2-yl)cyclohex-3-ene-1, 2-diol and its derivatives against influenza A(H1N1)2009 virus. Lett. Drug Des. Discov., 2011, 8(4), 375-380.
13. Kapitsa, I.G.; Suslov, E.V.; Teplov, G.V.; Korchagina, D.V.; Ko-marova, N.I.; Volcho, K.P.; Voronina, T.A.; Shevela, A.I.; Salak-hutdinov N.F. Synthesis and anxiolytic activity of 2-aminoadamantane derivatives containing monoterpene fragments. Pharm. Chem. Journ., 2012, 46(5), 263-265.
14. Kiesgen de Richter, R.; Bonato, M.; Follet, M.; Kamenka, J.M. The (+)- and (-)-[2-(1, 3-dithianyl)]myrtanylborane. Solid and stable monoalkylboranes for asymmetric hydroboration. J. Org. Chem., 1990, 55(9), 2855-2860.
15. Ardashov, O. V.; Il'ina, I. V.; Korchagina, D. V.; Volcho, K. P.; Salakhutdinov, N. F. Unusual &-hydroxyaldehyde with a cyclopen-tane framework from verbenol epoxide. Mendeleev Commun., 2007, 17(5), 303-305.
16. Il'ina, I. V.; Koneva, E. A.; Korchagina, D. V.; Sal'nikov, G. E.; Genaev, A. M.; Volcho, K. P.; Salakhutdinov, N. F. Chiral Schiff bases synthesized from terpenes of pinane series in asymmetric metal complex oxidation of sulfides. Russ. J. Org. Chem., 2012, 48(2), 214-220.
17. Sokolov, D. N.; Zarubaev, V. V.; Shtro, A. A; Polovinka, M. P.; Luzina, O. A.; Komarova, N. I.; Salakhutdinov, N. F.; Kiselev, O. I. Anti-viral activity of (-)- and (+)-usnic acids and their derivatives against influenza virus A(H1N1)2009. Bioorg. Med. Chem. Lett., 2012, 22(23), 7060-7064.
18. Pielak, R. M.; Schnell, J. R.; Chou, J. J. Mechanism of drug inhibition and drug resistance of influenza A M2 channel. Proc. Natl. Acad. Sci. U. S. A., 2009, 106(18), 7379-7384.
19. Rosenberg, M. R.; Casarotto, M. G. Coexistence of two adaman-tane binding sites in the influenza A M2 ion channel. Proc. Natl. Acad. Sci. U. S. A., 2010, 107(31), 13866-13871.
20. Du, Q. S.; Huang, R. B.; Wang, C. H.; Li, X. M.; Chou, K. C. Energetic analysis of the two controversial drug binding sites of the M2 proton channel in influenza A virus. J Theor. Biol., 2009, 259(1), 159-164.